FibroBiologics Inc (FBLG)
2.60
+0.19
(+7.88%)
USD |
NASDAQ |
Nov 22, 16:00
2.59
-0.01
(-0.38%)
After-Hours: 20:00
FibroBiologics Total Liabilities (Quarterly): 7.732M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.732M |
| June 30, 2024 | 11.30M |
| March 31, 2024 | 15.26M |
| December 31, 2023 | 10.57M |
| Date | Value |
|---|---|
| September 30, 2023 | 2.761M |
| June 30, 2023 | 2.491M |
| December 31, 2022 | 8.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.491M
Minimum
Jun 2023
15.26M
Maximum
Mar 2024
8.419M
Average
8.82M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Charles River Laboratories International Inc | 4.176B |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.47M |
| Shareholders Equity (Quarterly) | 2.737M |